Table 1 Sociodemographic and clinical characteristics of the study population
Parameter | CKD (n = 40) | CAPD (n = 40) | HD (n = 40) | Controls (n = 41) |
|---|---|---|---|---|
Age | 41.0 (36.0–51.5) | 39.5 (35.0–46.5) | 40.5 (36.0–49.0) | 41.0 (29.0–48.0) |
DOD (years) | 3.0 (1.5–4.0) | 3.0 (2.0–6.5) | ||
Gender (n/%) | ||||
Female | 20 (50.0) | 19 (47.5) | 18 (45.0) | 23 (56.1) |
Male | 20 (50.0) | 21 (52.5) | 22 (55.0) | 18 (43.9) |
BMI | ||||
< 30 kg/m2 | 19 (47.5) | 31 (77.5) | 32 (80.0) | 25 (61.0) |
> 30 kg/m2 | 21 (52.5) | 9 (22.5) | 8 (20.0) | 16 (39.0) |
WHR | ||||
Normal | 12 (30.0) | 9 (22.5) | 15 (37.5) | 28 (68.3) |
Increased | 28 (70.0) | 31 (72.5) | 25 (62.5) | 13 (31.7) |
Hypertensiona | ||||
Absent | 15 (37.5) | 12 (30) | 17 (17.5) | 34 (82.9) |
Present | 25 (62.5) | 28 (70) | 33 (82.5) | 7 (17.1) |
SCr (μmol/l) | 124 (106–166) | 1175 (878–1345) | 513 (405–712 | 80 (63–89) |
Albumin (g/l) | 41.5 (38.5–44.0) | 35.5 (33.0–40.0) | 38.5 (35.0–41.0) | 44.0 (42.0–45.0) |
TC (mmol/l) | ||||
< 5.17 | 31 (77.5) | 19 (47.5) | 40 (100) | 36 (87.8) |
> 5.17 | 9 (22.5) | 21 (52.5) | 0 | 5 (12.2) |
LDL | ||||
< 2.59 | 19 (47.5) | 14 (35.0) | 36 (90.0) | 21 (51.2) |
> 2.59 | 21 (52.5) | 26 (65.0) | 4 (10.0) | 20 (48.8) |
HDLb | ||||
Low | 30 (75.0) | 21 (52.5) | 15 (37.5) | 23 (56.1) |
Normal | 10 (25.0) | 19 (47.5) | 25 (62.5) | 18 (43.9) |
SU (n/%) | ||||
Yes | 7 (17.5) | 14 (35.0) | 7 (17.5) | |
No | 33 (82.5) | 26 (65.0) | 33 (82.5) | |
AAU (n/%) | ||||
Yes | 7 (17.5) | 11 (27.5) | 8 (20.0) | |
No | 33 (82.5) | 29 (72.5) | 32 (80.0) | |
PBU (n/%) | ||||
Yes | 2 (5.0) | 32 (80.0) | 32 (80.0) | |
No | 38 (95.0) | 8 (20.0) | 8 (20.0) | |
AsVD (n/%) | ||||
Absent | 21 (52.5) | 12 (30.0) | 21 (52.5) | 34 (82.9) |
Present | 19 (47.5) | 28 (70.0) | 19 (47.5) | 7 (17.1) |